Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Nuclear receptors as therapeutic targets for Alzheimer's disease.

Mandrekar-Colucci S, Landreth GE.

Expert Opin Ther Targets. 2011 Sep;15(9):1085-97. doi: 10.1517/14728222.2011.594043. Epub 2011 Jul 1. Review.

2.

PPARgamma agonists as therapeutics for the treatment of Alzheimer's disease.

Landreth G, Jiang Q, Mandrekar S, Heneka M.

Neurotherapeutics. 2008 Jul;5(3):481-9. doi: 10.1016/j.nurt.2008.05.003. Review.

3.
4.
5.

Advances in the identification of γ-secretase inhibitors for the treatment of Alzheimer's disease.

D'Onofrio G, Panza F, Frisardi V, Solfrizzi V, Imbimbo BP, Paroni G, Cascavilla L, Seripa D, Pilotto A.

Expert Opin Drug Discov. 2012 Jan;7(1):19-37. doi: 10.1517/17460441.2012.645534. Epub 2011 Dec 14. Review.

PMID:
22468891
6.

Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease.

Yan Q, Zhang J, Liu H, Babu-Khan S, Vassar R, Biere AL, Citron M, Landreth G.

J Neurosci. 2003 Aug 20;23(20):7504-9.

7.

The blood-brain barrier in Alzheimer's disease: novel therapeutic targets and nanodrug delivery.

Sharma HS, Castellani RJ, Smith MA, Sharma A.

Int Rev Neurobiol. 2012;102:47-90. doi: 10.1016/B978-0-12-386986-9.00003-X. Review.

PMID:
22748826
8.

Microglial interaction with beta-amyloid: implications for the pathogenesis of Alzheimer's disease.

Bamberger ME, Landreth GE.

Microsc Res Tech. 2001 Jul 15;54(2):59-70. Review.

PMID:
11455613
9.

[Pathological changes induced by amyloid-β in Alzheimer's disease].

Takata K, Kitamura Y, Taniguchi T.

Yakugaku Zasshi. 2011 Jan;131(1):3-11. Review. Japanese.

10.

Receptor for advanced glycation endproduct modulators: a new therapeutic target in Alzheimer's disease.

Walker D, Lue LF, Paul G, Patel A, Sabbagh MN.

Expert Opin Investig Drugs. 2015 Mar;24(3):393-9. doi: 10.1517/13543784.2015.1001490. Epub 2015 Jan 14. Review.

PMID:
25586103
11.

Alzheimer's disease.

De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV.

Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Review.

PMID:
23225010
12.

Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors.

Zelcer N, Khanlou N, Clare R, Jiang Q, Reed-Geaghan EG, Landreth GE, Vinters HV, Tontonoz P.

Proc Natl Acad Sci U S A. 2007 Jun 19;104(25):10601-6. Epub 2007 Jun 11.

13.

M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease: implications in future therapy.

Fisher A, Pittel Z, Haring R, Bar-Ner N, Kliger-Spatz M, Natan N, Egozi I, Sonego H, Marcovitch I, Brandeis R.

J Mol Neurosci. 2003;20(3):349-56. Review.

PMID:
14501019
14.

PPARγ/RXRα-induced and CD36-mediated microglial amyloid-β phagocytosis results in cognitive improvement in amyloid precursor protein/presenilin 1 mice.

Yamanaka M, Ishikawa T, Griep A, Axt D, Kummer MP, Heneka MT.

J Neurosci. 2012 Nov 28;32(48):17321-31. doi: 10.1523/JNEUROSCI.1569-12.2012.

15.

Soothing the inflamed brain: effect of non-steroidal anti-inflammatory drugs on Alzheimer's disease pathology.

Hoozemans JJ, Veerhuis R, Rozemuller JM, Eikelenboom P.

CNS Neurol Disord Drug Targets. 2011 Feb;10(1):57-67. Review.

PMID:
21143138
16.

The role of inflammation in Alzheimer's disease.

Tuppo EE, Arias HR.

Int J Biochem Cell Biol. 2005 Feb;37(2):289-305. Review.

PMID:
15474976
17.

[A drug targeting intracellular amyloid-β and oxidative stress: apomorphine].

Ohyagi Y.

Rinsho Shinkeigaku. 2011 Nov;51(11):884-7. Japanese.

PMID:
22277403
18.

The multifunctional anti-inflammatory drugs used in the therapy of Alzheimer's disease.

Shi S, Wang Z, Qiao Z.

Curr Med Chem. 2013;20(20):2583-8. Review.

PMID:
23590711
19.

Gelsolin as therapeutic target in Alzheimer's disease.

Carro E.

Expert Opin Ther Targets. 2010 Jun;14(6):585-92. doi: 10.1517/14728222.2010.488222. Review.

PMID:
20433353
20.

Emerging targets in neurodegeneration: new opportunities for Alzheimer's disease treatment?

Rampa A, Gobbi S, Belluti F, Bisi A.

Curr Top Med Chem. 2013;13(15):1879-904. Review.

PMID:
23931436
Items per page

Supplemental Content

Write to the Help Desk